You have 7 free searches left this month | for more free features.

Lung Cancer Squamous Cell

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

Carcinoma, Renal Cell Trial in China (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +3 more
  • Beijing, Beijing, China
  • +16 more
Jun 2, 2023

Hematopoietic Cell Transplantation Recipient, Recurrent DLBCL, Recurrent Grade 1 Follicular Lymphoma Trial in Columbus

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • +11 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 29, 2021

Circulating Tumor DNA in Pancreatic Cancer UsingPersonalized

Recruiting
  • Pancreatic Cancer
  • No intervention
  • Kashiwa, Japan
    National Cancer Center Hospital East
Sep 12, 2023

Metabolic Syndrome, HEALTHY VOLUNTEERS, Time Restricted Feeding Trial in Amsterdam (Time Restricted Eating, normal diet)

Recruiting
  • Metabolic Syndrome
  • +4 more
  • Time Restricted Eating
  • normal diet
  • Amsterdam, Netherlands
    Amsterdam UMC location AMC
Jun 1, 2023

Lymphedema Severity on Shoulder Joint Function and Muscle

Recruiting
  • Breast Cancer
  • Breast Cancer Female
  • Lymphedema severity stratification
  • Al Ḩayy Ath Thāmin, Giza, Egypt
    Outpatient clinic of faculty of physical therapy, Ahram Canadian
Jul 5, 2023

Relapsed or Refractory B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in Beijing

Recruiting
  • Relapsed or Refractory B-cell Lymphoma
  • +6 more
  • Beijing, China
    Beijing Cancer Hospital
Feb 6, 2023

Acute Kidney Disease Trial in Taipei City (Azacitidine, Placebo)

Not yet recruiting
  • Acute Kidney Disease
  • Taipei City, Taiwan
    Yu Hsiang Chou
May 2, 2022

Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or

Terminated
  • Ovarian Cancer
  • Ovarian Neoplasms
  • 18F-EF5 PET/CT scan
  • Optional biopsy
  • Vancouver, British Columbia, Canada
    BC Cancer Agency - Vancouver Centre
Feb 2, 2022

Sickle Cell Anemia Trial in Santo Domingo (Hydroxyurea, TCD examination)

Active, not recruiting
  • Sickle Cell Anemia
  • Santo Domingo, Dominican Republic
    Encargada del Servicio de Hematología-Oncología Hospital Infanti
Jan 17, 2023

Gastric or Gastroesophageal Cancer Trial in Kawasaki-shi, Chuo-ku (FPA144)

Completed
  • Gastric or Gastroesophageal Cancer
  • Kawasaki-shi, Kanagawa, Japan
  • +1 more
Jun 13, 2023

Acute Myeloid Leukemia, MDS Trial in Bronx (Venetoclax Oral Tablet, Daunorubicin, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Venetoclax Oral Tablet
  • +2 more
  • Bronx, New York
    Montefiore Einstein Cancer Center
Jul 14, 2022

Metastatic Castration-resistant Prostate Cancer Trial in United States (AMG 340)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • AMG 340
  • San Francisco, California
  • +6 more
Jul 14, 2022

Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)

Recruiting
  • Fanconi Anemia
  • +2 more
  • Total Body Irradiation (TBI) (Plan 1)
  • +8 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 2, 2022

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Morgantown (Busulfan, Fludarabine)

Active, not recruiting
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • Morgantown, West Virginia
    West Virginia University Hospitals Mary Babb Randolph Cancer Cen
Apr 6, 2021

Anemia, Sickle Cell Trial in San Diego (HBI-002)

Not yet recruiting
  • Anemia, Sickle Cell
  • San Diego, California
    Contact Company
Nov 17, 2023

Pulmonary Hypertension, Hypersensitivity Pneumonitis Trial in Cairo (Right heart catheter)

Completed
  • Pulmonary Hypertension
  • Hypersensitivity Pneumonitis
  • Right heart catheter
  • Cairo, Egypt
    Kasr alainy school of medicine
Jul 12, 2022

Advanced Malignant Tumors Trial (AK127 Q3W IV infusion ,AK104 10mg/kg Q3W IV infusion)

Not yet recruiting
  • Advanced Malignant Tumors
  • AK127 Q3W IV infusion ,AK104 10mg/kg Q3W IV infusion
  • (no location specified)
May 11, 2023

Resectable Intrahepatic Cholangiocarcinoma, Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8, Stage I Intrahepatic

Not yet recruiting
  • Resectable Intrahepatic Cholangiocarcinoma
  • +4 more
  • Atlanta, Georgia
  • +2 more
Aug 19, 2022

Pleural Effusion, Malignant, Non-small Cell Carcinoma Trial in Seoul (intrapleural docetaxel administration)

Completed
  • Pleural Effusion, Malignant
  • Non-small Cell Carcinoma
  • intrapleural docetaxel administration
  • Seoul, Korea, Republic of
    Asan Medical Center
Mar 6, 2019

Multiple Myeloma Trial in Hamburg (allogeneic HSCT)

Completed
  • Multiple Myeloma
  • allogeneic HSCT
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
Sep 1, 2022

Bladder Bank (a Prospective Banking Study)

Recruiting
  • Bladder Carcinoma
  • Hematuria
  • Non-Interventional Study
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Oct 25, 2023

T-Cell Peripheral Lymphoma, Gamma Delta Hepatosplenic T-Cell Lymphoma, Subcutaneous Panniculitis-Like T-Cell Lymphoma Trial run

Completed
  • T-Cell Peripheral Lymphoma
  • +3 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 28, 2021

Lung Tumors, Thoracic Tumors, Tumors by Site Trial in Houston (MIMIG System, Indocyanine Green (ICG))

Terminated
  • Lung Neoplasms
  • +4 more
  • MIMIG System
  • Indocyanine Green (ICG)
  • Houston, Texas
    MD Anderson Cancer Center Interventional Radiology Dept.
Sep 10, 2021

Acute Ischemic Stroke Trial (exosomes derived from human induced pluripotent stem cell for injection, a of exosomes derived

Not yet recruiting
  • Acute Ischemic Stroke
  • exosomes derived from human induced pluripotent stem cell for injection
  • a placebo of exosomes derived from human induced pluripotent stem cell for injection
  • (no location specified)
Nov 15, 2023